Kidney Inflammation, Injury and Regeneration 2020
Acute kidney injury (AKI) is still associated with high morbidity and mortality incidence rates, and also bears an elevated risk of chronic kidney disease in the sequel. Whereas the kidney has a remarkable capacity for regeneration after injury and may recover completely depending on the type of ren...
Збережено в:
| Формат: | Online |
|---|---|
| Мова: | Англійська |
| Опубліковано: |
MDPI - Multidisciplinary Digital Publishing Institute
2022
|
| Предмети: | |
| Онлайн доступ: | ONIX_20220111_9783036523705_836 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|
| _version_ | 1869516807481589760 |
|---|---|
| collection | Directory of Open Access Books |
| description | Acute kidney injury (AKI) is still associated with high morbidity and mortality incidence rates, and also bears an elevated risk of chronic kidney disease in the sequel. Whereas the kidney has a remarkable capacity for regeneration after injury and may recover completely depending on the type of renal lesions, the options for clinical intervention are restricted to fluid management and extracorporeal kidney support. The development of novel therapies to prevent AKI, to improve renal regeneration capacity after AKI, and to preserve renal function—in both the short- and long-term—is urgently needed. This Special Issue includes papers investigating the pathological mechanisms of renal inflammation and AKI and diagnostics using new biomarkers. Furthermore, experimental in vitro and in vivo studies examining potential new approaches to attenuate kidney dysfunction are included, as well as review articles. |
| format | Online |
| id | doab-20.500.12854ir-77004 |
| institution | Directory of Open Access Books |
| language | eng |
| publishDate | 2022 |
| publishDateRange | 2022 |
| publishDateSort | 2022 |
| publisher | MDPI - Multidisciplinary Digital Publishing Institute |
| publisherStr | MDPI - Multidisciplinary Digital Publishing Institute |
| record_format | ojs |
| spelling | doab-20.500.12854ir-770042024-03-30T23:21:57Z Kidney Inflammation, Injury and Regeneration 2020 Baer, Patrick C. Koch, Benjamin Geiger, Helmut inflammation chronic kidney disease anemia anemia of inflammation ESA hyporesponsiveness renal tubular epithelial cells macrophages lipocalin-2 iron cilastatin hypoxia inducible factor-1-α ischemia-reperfusion injury acute kidney injury cyclophilin A fibrosis renal fibrosis tubular necrosis preeclampsia podocytes VEGF FSGS proteinuria endocan ESM-1 renal replacement therapy kidney transplantation biomarker diabetic nephropathy focal segmental glomerulosclerosis innate immunity membranous nephropathy minimal change diseases TLR NOX1 ML171 reactive oxygen species ERK T cells glomerulonephritis chemokines renal disease DJ-1 ND-13 renal inflammation oxidative stress UUO autophagy apoptosis trehalose simvastatin endotoxin tubular apoptosis cytochrome C Bcl-XL survivin hypercholesterolemia xanthine oxidase NF-κB pathway tertiary lymphoid organs B cells BAFF kidney fibrosis myofibroblast activation extracellular matrix Hippo pathway verteporfin IgAN CKD progression ACEI corticosteroids costimulation coinhibition kidney transplant SPR protein binding affinity adaptive immunity epithelial-to-mesenchymal transition E. cava extracts dieckol spontaneously hypertensive rats angiotensin II n/a thema EDItEUR::M Medicine and Nursing Acute kidney injury (AKI) is still associated with high morbidity and mortality incidence rates, and also bears an elevated risk of chronic kidney disease in the sequel. Whereas the kidney has a remarkable capacity for regeneration after injury and may recover completely depending on the type of renal lesions, the options for clinical intervention are restricted to fluid management and extracorporeal kidney support. The development of novel therapies to prevent AKI, to improve renal regeneration capacity after AKI, and to preserve renal function—in both the short- and long-term—is urgently needed. This Special Issue includes papers investigating the pathological mechanisms of renal inflammation and AKI and diagnostics using new biomarkers. Furthermore, experimental in vitro and in vivo studies examining potential new approaches to attenuate kidney dysfunction are included, as well as review articles. 2022-01-11T13:48:59Z 2022-01-11T13:48:59Z 2021 book ONIX_20220111_9783036523705_836 9783036523705 9783036523699 https://directory.doabooks.org/handle/20.500.12854/77004 eng image/jpeg Attribution 4.0 International https://mdpi.com/books/pdfview/book/4614 https://mdpi.com/books/pdfview/book/4614 MDPI - Multidisciplinary Digital Publishing Institute 10.3390/books978-3-0365-2369-9 10.3390/books978-3-0365-2369-9 46cabcaa-dd94-4bfe-87b4-55023c1b36d0 9783036523705 9783036523699 318 Basel, Switzerland open access |
| spellingShingle | inflammation chronic kidney disease anemia anemia of inflammation ESA hyporesponsiveness renal tubular epithelial cells macrophages lipocalin-2 iron cilastatin hypoxia inducible factor-1-α ischemia-reperfusion injury acute kidney injury cyclophilin A fibrosis renal fibrosis tubular necrosis preeclampsia podocytes VEGF FSGS proteinuria endocan ESM-1 renal replacement therapy kidney transplantation biomarker diabetic nephropathy focal segmental glomerulosclerosis innate immunity membranous nephropathy minimal change diseases TLR NOX1 ML171 reactive oxygen species ERK T cells glomerulonephritis chemokines renal disease DJ-1 ND-13 renal inflammation oxidative stress UUO autophagy apoptosis trehalose simvastatin endotoxin tubular apoptosis cytochrome C Bcl-XL survivin hypercholesterolemia xanthine oxidase NF-κB pathway tertiary lymphoid organs B cells BAFF kidney fibrosis myofibroblast activation extracellular matrix Hippo pathway verteporfin IgAN CKD progression ACEI corticosteroids costimulation coinhibition kidney transplant SPR protein binding affinity adaptive immunity epithelial-to-mesenchymal transition E. cava extracts dieckol spontaneously hypertensive rats angiotensin II n/a thema EDItEUR::M Medicine and Nursing Kidney Inflammation, Injury and Regeneration 2020 |
| title | Kidney Inflammation, Injury and Regeneration 2020 |
| title_full | Kidney Inflammation, Injury and Regeneration 2020 |
| title_fullStr | Kidney Inflammation, Injury and Regeneration 2020 |
| title_full_unstemmed | Kidney Inflammation, Injury and Regeneration 2020 |
| title_short | Kidney Inflammation, Injury and Regeneration 2020 |
| title_sort | kidney inflammation injury and regeneration 2020 |
| topic | inflammation chronic kidney disease anemia anemia of inflammation ESA hyporesponsiveness renal tubular epithelial cells macrophages lipocalin-2 iron cilastatin hypoxia inducible factor-1-α ischemia-reperfusion injury acute kidney injury cyclophilin A fibrosis renal fibrosis tubular necrosis preeclampsia podocytes VEGF FSGS proteinuria endocan ESM-1 renal replacement therapy kidney transplantation biomarker diabetic nephropathy focal segmental glomerulosclerosis innate immunity membranous nephropathy minimal change diseases TLR NOX1 ML171 reactive oxygen species ERK T cells glomerulonephritis chemokines renal disease DJ-1 ND-13 renal inflammation oxidative stress UUO autophagy apoptosis trehalose simvastatin endotoxin tubular apoptosis cytochrome C Bcl-XL survivin hypercholesterolemia xanthine oxidase NF-κB pathway tertiary lymphoid organs B cells BAFF kidney fibrosis myofibroblast activation extracellular matrix Hippo pathway verteporfin IgAN CKD progression ACEI corticosteroids costimulation coinhibition kidney transplant SPR protein binding affinity adaptive immunity epithelial-to-mesenchymal transition E. cava extracts dieckol spontaneously hypertensive rats angiotensin II n/a thema EDItEUR::M Medicine and Nursing |
| topic_facet | inflammation chronic kidney disease anemia anemia of inflammation ESA hyporesponsiveness renal tubular epithelial cells macrophages lipocalin-2 iron cilastatin hypoxia inducible factor-1-α ischemia-reperfusion injury acute kidney injury cyclophilin A fibrosis renal fibrosis tubular necrosis preeclampsia podocytes VEGF FSGS proteinuria endocan ESM-1 renal replacement therapy kidney transplantation biomarker diabetic nephropathy focal segmental glomerulosclerosis innate immunity membranous nephropathy minimal change diseases TLR NOX1 ML171 reactive oxygen species ERK T cells glomerulonephritis chemokines renal disease DJ-1 ND-13 renal inflammation oxidative stress UUO autophagy apoptosis trehalose simvastatin endotoxin tubular apoptosis cytochrome C Bcl-XL survivin hypercholesterolemia xanthine oxidase NF-κB pathway tertiary lymphoid organs B cells BAFF kidney fibrosis myofibroblast activation extracellular matrix Hippo pathway verteporfin IgAN CKD progression ACEI corticosteroids costimulation coinhibition kidney transplant SPR protein binding affinity adaptive immunity epithelial-to-mesenchymal transition E. cava extracts dieckol spontaneously hypertensive rats angiotensin II n/a thema EDItEUR::M Medicine and Nursing |
| url | ONIX_20220111_9783036523705_836 |